Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
7 reports, 3 independent
Updated Oct 15
Gone quiet
- Reports
- 7
- Developments
- 4
- Repetition
- 43%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.RBC issued a stock rating for Praxis Precision Medicines, which is listed on Nasdaq.1 source
Raymond James raised price target and buy rating for Praxis Precision Medicines.1 source
Stock up $50.93; enrollment exceeded target for supplemental FDA filing.1 source
Praxis Precision Medicines listed on Nasdaq.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Praxis Precision Medicines and Relay Therapeutics were listed on the Nasdaq stock exchange on October 1, 2026.
- Materialise listed its shares on the Nasdaq stock exchange on August 27, 2026.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.
- Koss Corporation was listed on the stock exchange on August 1, 2026.
- BioMarin Pharmaceutical and CollPlant Biotechnologies were listed on Nasdaq and are being compared as healthcare companies.